These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [The agony and (rational) alternative. Recommendations of the drug commission on antidementia agents]. Dietmaier O Pharm Unserer Zeit; 2002; 31(4):394-400. PubMed ID: 12162070 [No Abstract] [Full Text] [Related]
4. When should drug treatment be started for people with dementia? Singh B; O'Brien JT Maturitas; 2009 Mar; 62(3):230-4. PubMed ID: 19201114 [TBL] [Abstract][Full Text] [Related]
5. [Early treatment with anti-dementia drugs when possible. These signs reveal Alzheimer disease]. MMW Fortschr Med; 2003 Jun; 145(23):60. PubMed ID: 12854234 [No Abstract] [Full Text] [Related]
6. [New options for the pharmacotherapy of Alzheimer disease after the approval of memantine? Re the article from DMW 8/2005]. Wellhöfer B Dtsch Med Wochenschr; 2006 Feb; 131(6):284. PubMed ID: 16463237 [No Abstract] [Full Text] [Related]
9. FDA approves memantine drug for treating AD. Am J Alzheimers Dis Other Demen; 2003; 18(6):329-30. PubMed ID: 14682078 [No Abstract] [Full Text] [Related]
10. Cholinesterase inhibitors and memantine have a role in the treatment of Alzheimer's disease. Rabins PV; Lyketsos CG Nat Clin Pract Neurol; 2006 Nov; 2(11):578-9. PubMed ID: 17057739 [No Abstract] [Full Text] [Related]
11. Discontinuing Alzheimer's disease drug therapy: why, when, and how. Crutchfield D Director; 2008; 16(1):19-21. PubMed ID: 19343870 [TBL] [Abstract][Full Text] [Related]
13. Memantine in the treatment of dementia. Maggiore C; Locatelli L; Grandi FC; Pizzolato G; Neuroepidemiology; 2007; 28(2):118-9. PubMed ID: 17409774 [No Abstract] [Full Text] [Related]
14. [Psychotropic drug treatment in dementia disorders]. Richartz E; Schott KJ; Wormstall H Dtsch Med Wochenschr; 2004 Jun; 129(25-26):1434-40. PubMed ID: 15213876 [No Abstract] [Full Text] [Related]
15. Ketamine followed by memantine for the treatment of major depression. Kollmar R; Markovic K; Thürauf N; Schmitt H; Kornhuber J Aust N Z J Psychiatry; 2008 Feb; 42(2):170. PubMed ID: 18197514 [No Abstract] [Full Text] [Related]
16. [The action of memantine on the cognitive disorders of patients with dementia: reflections following two years' experience in Spain]. Robles-Bayón A Rev Neurol; 2006 Mar 1-15; 42(5):288-96. PubMed ID: 16538592 [TBL] [Abstract][Full Text] [Related]
17. Randomized controlled trial of memantine in dementia associated with Parkinson's disease. Leroi I; Overshott R; Byrne EJ; Daniel E; Burns A Mov Disord; 2009 Jun; 24(8):1217-21. PubMed ID: 19370737 [TBL] [Abstract][Full Text] [Related]
18. [Pharmacological therapy in Alzheimer's disease. Current clinical practice in The Netherlands]. Schölzel-Dorenbos CJ; Tijdschr Gerontol Geriatr; 2005 Jul; 36(3):122-6. PubMed ID: 16078659 [TBL] [Abstract][Full Text] [Related]
19. Factors affecting usage patterns of memantine in Alzheimer disease. Lerner AJ; McClendon MJ; Sami SA; Ogrocki PK; Adams KB; Smyth KA Alzheimer Dis Assoc Disord; 2008; 22(2):137-43. PubMed ID: 18525285 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of degenerative dementia disorders--who should be treated?]. Hasselbalch SG; Kampmann JP Ugeskr Laeger; 2009 Mar; 171(10):802-5. PubMed ID: 19265606 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]